Global Acute Sinusitis Market: Industry Analysis and Forecast (2019-2026) – By Type of Sinusitis, Treatment of Sinusitis, End User and Region.

Global Acute Sinusitis Market: Industry Analysis and Forecast (2019-2026) – By Type of Sinusitis, Treatment of Sinusitis, End User and Region.

Market Scenario

Global Acute Sinusitis Market was valued US$ XX Bn in 2019 and is expected to reach XX Bn by 2026, at a CAGR of XX % during a forecast period. Intranasal allergies, hay fever, nasal polyps, infected adenoids, deviated nasal septum, and cystic fibrosis is some of the factors, which are causing the occurrence of the acute sinusitis. The Symptoms of acute sinusitis include nasal congestion, sore throat, cough, headache, bad breath, pressure, and tenderness behind eyes- nose-cheeks- forehead. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. The growing number of patients suffering from acute sinusitis, where advancement in diagnostic tests and the use of various medications for the treatment like nasal sprays, nasal corticosteroids, and decongestants are some of the prominent factors behind the growth of the global acute sinusitis market. On the other hand, the lack of awareness about the diagnosis for the treatment of acute sinusitis is expected to limit the growth of the global acute sinusitis market. Acute sinusitis is also known as acute rhinosinusitis, which is a short-term inflammation of the membranes, line on the nose and surrounding sinuses. This impedes the ability to drain mucus from the nose and sinuses. On the other hand, the chronic sinusitis segment is expected to contribute significant growth in the global acute sinusitis market. If the symptoms of sinusitis continue for 12 weeks or longer, the doctor may diagnose chronic sinusitis. Chronic sinusitis is not generally bacterial in nature, so antibiotics are implausible to resolve symptoms. Corticosteroid sprays can benefit in recurrent cases, which mandatory require a prescription and medical supervision. Region-wise, North America is estimated to hold a dominant position in the global acute sinusitis market. The dominant position in the market is attributed to the increasing occurrence of chronic diseases and the technological advancements in diagnostic testing in the region. Sinus infection is a major health problem. It affects nearly about 31 Mn people in the United States. Americans spend more than $1 billion on over-the-counter medications to treat sinusitis every year. People who have allergies, asthma, structural blockages in the nose or sinuses, or people with weak invulnerable systems are at greater risk. The emergence of biologics is one of the key trends in the global acute sinusitis market. Currently, omalizumab has evolved as the most suitable candidate. Omalizumab is a drug, which recombinant humanized monoclonal antibody. This drug has been approved for the treatment of severe allergic asthma in the US and Europe. Scientists are assessing Omalizumab on the parameters of safety and efficacy for the treatment of chronic rhinosinusitis with nasal polyps. The successful launch of biologics like omalizumab is expected to drive growth in the global acute sinusitis market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the Global Acute Sinusitis Market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Acute Sinusitis Market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.

The Scope of the Report for Global Acute Sinusitis Market

Global Acute Sinusitis Market, By Type of Sinusitis

• Acute Sinusitis • Sub-acute Sinusitis • Chronic Sinusitis

Global Acute Sinusitis Market, By Treatment of Sinusitis

• Allergen Immunotherapy • Antibiotics • Antihistamines and Decongestants • Expectorants • Nasal Corticosteroids • Oral Corticosteroids

Global Acute Sinusitis Market, By End User

• Hospitals & Clinics • ENTC Specialists • Research Institute • Others

Global Acute Sinusitis Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in Global Acute Sinusitis Market

• Bayer AG • AstraZeneca Plc • Eli Lilly And Company • Bristol-Myers Squibb • Sanofi • Abbott • Merck & Co, Inc. • Bristol-Myers Squibb • Reddy’s Laboratory • Novartis AG

Table of Contents

Global Acute Sinusitis Market

Table of Content 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Acute Sinusitis Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Acute Sinusitis Market Analysis and Forecast 6.1. Global Acute Sinusitis Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Acute Sinusitis Market Analysis and Forecast, by Type of Sinusitis 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 7.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Type of Sinusitis 7.5. Global Acute Sinusitis Market Analysis, by Type of Sinusitis 7.6. Global Acute Sinusitis Market Attractiveness Analysis, by Type of Sinusitis 8. Global Acute Sinusitis Market Analysis and Forecast, by Treatment of Sinusitis 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 8.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Treatment of Sinusitis 8.5. Global Acute Sinusitis Market Analysis, by Treatment of Sinusitis 8.6. Global Acute Sinusitis Market Attractiveness Analysis, by Treatment of Sinusitis 9. Global Acute Sinusitis Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Acute Sinusitis Market Value Share Analysis, by End User 9.4. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by End User 9.5. Global Acute Sinusitis Market Analysis, by End User 9.6. Global Acute Sinusitis Market Attractiveness Analysis, by End User 10. Global Acute Sinusitis Market Analysis, by Region 10.1. Global Acute Sinusitis Market Value Share Analysis, by Region 10.2. Global Acute Sinusitis Market Size (US$ Bn) Forecast, by Region 10.3. Global Acute Sinusitis Market Attractiveness Analysis, by Region 11. North America Acute Sinusitis Market Analysis 11.1. Key Findings 11.2. North America Acute Sinusitis Market Overview 11.3. North America Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 11.4. North America Acute Sinusitis Market Forecast, by Type of Sinusitis 11.4.1. Acute Sinusitis 11.4.2. Sub-acute Sinusitis 11.4.3. Chronic Sinusitis 11.5. North America Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 11.6. North America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.6.1. Allergen Immunotherapy 11.6.2. Antibiotics 11.6.3. Antihistamines and Decongestants 11.6.4. Expectorants 11.6.5. Nasal Corticosteroids 11.6.6. Oral Corticosteroids 11.7. North America Acute Sinusitis Market Value Share Analysis, by End User 11.8. North America Acute Sinusitis Market Forecast, by End User 11.8.1. Hospitals & Clinics 11.8.2. ENTC Specialists 11.8.3. Research Institute 11.8.4. Others 11.9. North America Acute Sinusitis Market Value Share Analysis, by Country 11.10. North America Acute Sinusitis Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Acute Sinusitis Market Analysis, by Country 11.12. U.S. Acute Sinusitis Market Forecast, by Type of Sinusitis 11.12.1. Acute Sinusitis 11.12.2. Sub-acute Sinusitis 11.12.3. Chronic Sinusitis 11.13. U.S. Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.13.1. Allergen Immunotherapy 11.13.2. Antibiotics 11.13.3. Antihistamines and Decongestants 11.13.4. Expectorants 11.13.5. Nasal Corticosteroids 11.13.6. Oral Corticosteroids 11.14. U.S. Acute Sinusitis Market Forecast, by End User 11.14.1. Hospitals & Clinics 11.14.2. ENTC Specialists 11.14.3. Research Institute 11.14.4. Others 11.15. Canada Acute Sinusitis Market Forecast, by Type of Sinusitis 11.15.1. Acute Sinusitis 11.15.2. Sub-acute Sinusitis 11.15.3. Chronic Sinusitis 11.16. Canada Acute Sinusitis Market Forecast, by Treatment of Sinusitis 11.16.1. Allergen Immunotherapy 11.16.2. Antibiotics 11.16.3. Antihistamines and Decongestants 11.16.4. Expectorants 11.16.5. Nasal Corticosteroids 11.16.6. Oral Corticosteroids 11.17. Canada Acute Sinusitis Market Forecast, by End User 11.17.1. Hospitals & Clinics 11.17.2. ENTC Specialists 11.17.3. Research Institute 11.17.4. Others 11.18. North America Acute Sinusitis Market Attractiveness Analysis 11.18.1. By Type of Sinusitis 11.18.2. By Treatment of Sinusitis 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Acute Sinusitis Market Analysis 12.1. Key Findings 12.2. Europe Acute Sinusitis Market Overview 12.3. Europe Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 12.4. Europe Acute Sinusitis Market Forecast, by Type of Sinusitis 12.4.1. Acute Sinusitis 12.4.2. Sub-acute Sinusitis 12.4.3. Chronic Sinusitis 12.5. Europe Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 12.6. Europe Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.6.1. Allergen Immunotherapy 12.6.2. Antibiotics 12.6.3. Antihistamines and Decongestants 12.6.4. Expectorants 12.6.5. Nasal Corticosteroids 12.6.6. Oral Corticosteroids 12.7. Europe Acute Sinusitis Market Value Share Analysis, by End User 12.8. Europe Acute Sinusitis Market Forecast, by End User 12.8.1. Hospitals & Clinics 12.8.2. ENTC Specialists 12.8.3. Research Institute 12.8.4. Others 12.9. Europe Acute Sinusitis Market Value Share Analysis, by Country 12.10. Europe Acute Sinusitis Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Acute Sinusitis Market Analysis, by Country 12.12. Germany Acute Sinusitis Market Forecast, by Type of Sinusitis 12.12.1. Acute Sinusitis 12.12.2. Sub-acute Sinusitis 12.12.3. Chronic Sinusitis 12.13. Germany Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.13.1. Allergen Immunotherapy 12.13.2. Antibiotics 12.13.3. Antihistamines and Decongestants 12.13.4. Expectorants 12.13.5. Nasal Corticosteroids 12.13.6. Oral Corticosteroids 12.14. Germany Acute Sinusitis Market Forecast, by End User 12.14.1. Hospitals & Clinics 12.14.2. ENTC Specialists 12.14.3. Research Institute 12.14.4. Others 12.15. U.K. Acute Sinusitis Market Forecast, by Type of Sinusitis 12.15.1. Acute Sinusitis 12.15.2. Sub-acute Sinusitis 12.15.3. Chronic Sinusitis 12.16. U.K. Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.16.1. Allergen Immunotherapy 12.16.2. Antibiotics 12.16.3. Antihistamines and Decongestants 12.16.4. Expectorants 12.16.5. Nasal Corticosteroids 12.16.6. Oral Corticosteroids 12.17. U.K. Acute Sinusitis Market Forecast, by End User 12.17.1. Hospitals & Clinics 12.17.2. ENTC Specialists 12.17.3. Research Institute 12.17.4. Others 12.18. France Acute Sinusitis Market Forecast, by Type of Sinusitis 12.18.1. Acute Sinusitis 12.18.2. Sub-acute Sinusitis 12.18.3. Chronic Sinusitis 12.19. France Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.19.1. Allergen Immunotherapy 12.19.2. Antibiotics 12.19.3. Antihistamines and Decongestants 12.19.4. Expectorants 12.19.5. Nasal Corticosteroids 12.19.6. Oral Corticosteroids 12.20. France Acute Sinusitis Market Forecast, by End User 12.20.1. Hospitals & Clinics 12.20.2. ENTC Specialists 12.20.3. Research Institute 12.20.4. Others 12.21. Italy Acute Sinusitis Market Forecast, by Type of Sinusitis 12.21.1. Acute Sinusitis 12.21.2. Sub-acute Sinusitis 12.21.3. Chronic Sinusitis 12.22. Italy Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.22.1. Allergen Immunotherapy 12.22.2. Antibiotics 12.22.3. Antihistamines and Decongestants 12.22.4. Expectorants 12.22.5. Nasal Corticosteroids 12.22.6. Oral Corticosteroids 12.23. Italy Acute Sinusitis Market Forecast, by End User 12.23.1. Hospitals & Clinics 12.23.2. ENTC Specialists 12.23.3. Research Institute 12.23.4. Others 12.24. Spain Acute Sinusitis Market Forecast, by Type of Sinusitis 12.24.1. Acute Sinusitis 12.24.2. Sub-acute Sinusitis 12.24.3. Chronic Sinusitis 12.25. Spain Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.25.1. Allergen Immunotherapy 12.25.2. Antibiotics 12.25.3. Antihistamines and Decongestants 12.25.4. Expectorants 12.25.5. Nasal Corticosteroids 12.25.6. Oral Corticosteroids 12.26. Spain Acute Sinusitis Market Forecast, by End User 12.26.1. Hospitals & Clinics 12.26.2. ENTC Specialists 12.26.3. Research Institute 12.26.4. Others 12.27. Rest of Europe Acute Sinusitis Market Forecast, by Type of Sinusitis 12.27.1. Acute Sinusitis 12.27.2. Sub-acute Sinusitis 12.27.3. Chronic Sinusitis 12.28. Rest of Europe Acute Sinusitis Market Forecast, by Treatment of Sinusitis 12.28.1. Allergen Immunotherapy 12.28.2. Antibiotics 12.28.3. Antihistamines and Decongestants 12.28.4. Expectorants 12.28.5. Nasal Corticosteroids 12.28.6. Oral Corticosteroids 12.29. Rest Of Europe Acute Sinusitis Market Forecast, by End User 12.29.1. Hospitals & Clinics 12.29.2. ENTC Specialists 12.29.3. Research Institute 12.29.4. Others 12.30. Europe Acute Sinusitis Market Attractiveness Analysis 12.30.1. By Type of Sinusitis 12.30.2. By Treatment of Sinusitis 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Acute Sinusitis Market Analysis 13.1. Key Findings 13.2. Asia Pacific Acute Sinusitis Market Overview 13.3. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 13.4. Asia Pacific Acute Sinusitis Market Forecast, by Type of Sinusitis 13.4.1. Acute Sinusitis 13.4.2. Sub-acute Sinusitis 13.4.3. Chronic Sinusitis 13.5. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 13.6. Asia Pacific Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.6.1. Allergen Immunotherapy 13.6.2. Antibiotics 13.6.3. Antihistamines and Decongestants 13.6.4. Expectorants 13.6.5. Nasal Corticosteroids 13.6.6. Oral Corticosteroids 13.7. Asia Pacific Acute Sinusitis Market Value Share Analysis, by End User 13.8. Asia Pacific Acute Sinusitis Market Forecast, by End User 13.8.1. Hospitals & Clinics 13.8.2. ENTC Specialists 13.8.3. Research Institute 13.8.4. Others 13.9. Asia Pacific Acute Sinusitis Market Value Share Analysis, by Country 13.10. Asia Pacific Acute Sinusitis Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Acute Sinusitis Market Analysis, by Country 13.12. China Acute Sinusitis Market Forecast, by Type of Sinusitis 13.12.1. Acute Sinusitis 13.12.2. Sub-acute Sinusitis 13.12.3. Chronic Sinusitis 13.13. China Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.13.1. Allergen Immunotherapy 13.13.2. Antibiotics 13.13.3. Antihistamines and Decongestants 13.13.4. Expectorants 13.13.5. Nasal Corticosteroids 13.13.6. Oral Corticosteroids 13.14. China Acute Sinusitis Market Forecast, by End User 13.14.1. Hospitals & Clinics 13.14.2. ENTC Specialists 13.14.3. Research Institute 13.14.4. Others 13.15. India Acute Sinusitis Market Forecast, by Type of Sinusitis 13.15.1. Acute Sinusitis 13.15.2. Sub-acute Sinusitis 13.15.3. Chronic Sinusitis 13.16. India Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.16.1. Allergen Immunotherapy 13.16.2. Antibiotics 13.16.3. Antihistamines and Decongestants 13.16.4. Expectorants 13.16.5. Nasal Corticosteroids 13.16.6. Oral Corticosteroids 13.17. India Acute Sinusitis Market Forecast, by End User 13.17.1. Hospitals & Clinics 13.17.2. ENTC Specialists 13.17.3. Research Institute 13.17.4. Others 13.18. Japan Acute Sinusitis Market Forecast, by Type of Sinusitis 13.18.1. Acute Sinusitis 13.18.2. Sub-acute Sinusitis 13.18.3. Chronic Sinusitis 13.19. Japan Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.19.1. Allergen Immunotherapy 13.19.2. Antibiotics 13.19.3. Antihistamines and Decongestants 13.19.4. Expectorants 13.19.5. Nasal Corticosteroids 13.19.6. Oral Corticosteroids 13.20. Japan Acute Sinusitis Market Forecast, by End User 13.20.1. Hospitals & Clinics 13.20.2. ENTC Specialists 13.20.3. Research Institute 13.20.4. Others 13.21. ASEAN Acute Sinusitis Market Forecast, by Type of Sinusitis 13.21.1. Acute Sinusitis 13.21.2. Sub-acute Sinusitis 13.21.3. Chronic Sinusitis 13.22. ASEAN Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.22.1. Allergen Immunotherapy 13.22.2. Antibiotics 13.22.3. Antihistamines and Decongestants 13.22.4. Expectorants 13.22.5. Nasal Corticosteroids 13.22.6. Oral Corticosteroids 13.23. ASEAN Acute Sinusitis Market Forecast, by End User 13.23.1. Hospitals & Clinics 13.23.2. ENTC Specialists 13.23.3. Research Institute 13.23.4. Others 13.24. Rest of Asia Pacific Acute Sinusitis Market Forecast, by Type of Sinusitis 13.24.1. Acute Sinusitis 13.24.2. Sub-acute Sinusitis 13.24.3. Chronic Sinusitis 13.25. Rest of Asia Pacific Acute Sinusitis Market Forecast, by Treatment of Sinusitis 13.25.1. Allergen Immunotherapy 13.25.2. Antibiotics 13.25.3. Antihistamines and Decongestants 13.25.4. Expectorants 13.25.5. Nasal Corticosteroids 13.25.6. Oral Corticosteroids 13.26. Rest of Asia Pacific Acute Sinusitis Market Forecast, by End User 13.26.1. Hospitals & Clinics 13.26.2. ENTC Specialists 13.26.3. Research Institute 13.26.4. Others 13.27. Asia Pacific Acute Sinusitis Market Attractiveness Analysis 13.27.1. By Type of Sinusitis 13.27.2. By Treatment of Sinusitis 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Acute Sinusitis Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Acute Sinusitis Market Overview 14.3. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 14.4. Middle East & Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.4.1. Acute Sinusitis 14.4.2. Sub-acute Sinusitis 14.4.3. Chronic Sinusitis 14.5. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 14.6. Middle East & Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.6.1. Allergen Immunotherapy 14.6.2. Antibiotics 14.6.3. Antihistamines and Decongestants 14.6.4. Expectorants 14.6.5. Nasal Corticosteroids 14.6.6. Oral Corticosteroids 14.7. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by End User 14.8. Middle East & Africa Acute Sinusitis Market Forecast, by End User 14.8.1. Hospitals & Clinics 14.8.2. ENTC Specialists 14.8.3. Research Institute 14.8.4. Others 14.9. Middle East & Africa Acute Sinusitis Market Value Share Analysis, by Country 14.10. Middle East & Africa Acute Sinusitis Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Acute Sinusitis Market Analysis, by Country 14.12. GCC Acute Sinusitis Market Forecast, by Type of Sinusitis 14.12.1. Acute Sinusitis 14.12.2. Sub-acute Sinusitis 14.12.3. Chronic Sinusitis 14.13. GCC Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.13.1. Allergen Immunotherapy 14.13.2. Antibiotics 14.13.3. Antihistamines and Decongestants 14.13.4. Expectorants 14.13.5. Nasal Corticosteroids 14.13.6. Oral Corticosteroids 14.14. GCC Acute Sinusitis Market Forecast, by End User 14.14.1. Hospitals & Clinics 14.14.2. ENTC Specialists 14.14.3. Research Institute 14.14.4. Others 14.15. South Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.15.1. Acute Sinusitis 14.15.2. Sub-acute Sinusitis 14.15.3. Chronic Sinusitis 14.16. South Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.16.1. Allergen Immunotherapy 14.16.2. Antibiotics 14.16.3. Antihistamines and Decongestants 14.16.4. Expectorants 14.16.5. Nasal Corticosteroids 14.16.6. Oral Corticosteroids 14.17. South Africa Acute Sinusitis Market Forecast, by End User 14.17.1. Hospitals & Clinics 14.17.2. ENTC Specialists 14.17.3. Research Institute 14.17.4. Others 14.18. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by Type of Sinusitis 14.18.1. Acute Sinusitis 14.18.2. Sub-acute Sinusitis 14.18.3. Chronic Sinusitis 14.19. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by Treatment of Sinusitis 14.19.1. Allergen Immunotherapy 14.19.2. Antibiotics 14.19.3. Antihistamines and Decongestants 14.19.4. Expectorants 14.19.5. Nasal Corticosteroids 14.19.6. Oral Corticosteroids 14.20. Rest of Middle East & Africa Acute Sinusitis Market Forecast, by End User 14.20.1. Hospitals & Clinics 14.20.2. ENTC Specialists 14.20.3. Research Institute 14.20.4. Others 14.21. Middle East & Africa Acute Sinusitis Market Attractiveness Analysis 14.21.1. By Type of Sinusitis 14.21.2. By Treatment of Sinusitis 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Acute Sinusitis Market Analysis 15.1. Key Findings 15.2. South America Acute Sinusitis Market Overview 15.3. South America Acute Sinusitis Market Value Share Analysis, by Type of Sinusitis 15.4. South America Acute Sinusitis Market Forecast, by Type of Sinusitis 15.4.1. Acute Sinusitis 15.4.2. Sub-acute Sinusitis 15.4.3. Chronic Sinusitis 15.5. South America Acute Sinusitis Market Value Share Analysis, by Treatment of Sinusitis 15.6. South America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.6.1. Allergen Immunotherapy 15.6.2. Antibiotics 15.6.3. Antihistamines and Decongestants 15.6.4. Expectorants 15.6.5. Nasal Corticosteroids 15.6.6. Oral Corticosteroids 15.7. South America Acute Sinusitis Market Value Share Analysis, by End User 15.8. South America Acute Sinusitis Market Forecast, by End User 15.8.1. Hospitals & Clinics 15.8.2. ENTC Specialists 15.8.3. Research Institute 15.8.4. Others 15.9. South America Acute Sinusitis Market Value Share Analysis, by Country 15.10. South America Acute Sinusitis Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Acute Sinusitis Market Analysis, by Country 15.12. Brazil Acute Sinusitis Market Forecast, by Type of Sinusitis 15.12.1. Acute Sinusitis 15.12.2. Sub-acute Sinusitis 15.12.3. Chronic Sinusitis 15.13. Brazil Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.13.1. Allergen Immunotherapy 15.13.2. Antibiotics 15.13.3. Antihistamines and Decongestants 15.13.4. Expectorants 15.13.5. Nasal Corticosteroids 15.13.6. Oral Corticosteroids 15.14. Brazil Acute Sinusitis Market Forecast, by End User 15.14.1. Hospitals & Clinics 15.14.2. ENTC Specialists 15.14.3. Research Institute 15.14.4. Others 15.15. Mexico Acute Sinusitis Market Forecast, by Type of Sinusitis 15.15.1. Acute Sinusitis 15.15.2. Sub-acute Sinusitis 15.15.3. Chronic Sinusitis 15.16. Mexico Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.16.1. Allergen Immunotherapy 15.16.2. Antibiotics 15.16.3. Antihistamines and Decongestants 15.16.4. Expectorants 15.16.5. Nasal Corticosteroids 15.16.6. Oral Corticosteroids 15.17. Mexico Acute Sinusitis Market Forecast, by End User 15.17.1. Hospitals & Clinics 15.17.2. ENTC Specialists 15.17.3. Research Institute 15.17.4. Others 15.18. Rest of South America Acute Sinusitis Market Forecast, by Type of Sinusitis 15.18.1. Acute Sinusitis 15.18.2. Sub-acute Sinusitis 15.18.3. Chronic Sinusitis 15.19. Rest of South America Acute Sinusitis Market Forecast, by Treatment of Sinusitis 15.19.1. Allergen Immunotherapy 15.19.2. Antibiotics 15.19.3. Antihistamines and Decongestants 15.19.4. Expectorants 15.19.5. Nasal Corticosteroids 15.19.6. Oral Corticosteroids 15.20. Rest of South America Acute Sinusitis Market Forecast, by End User 15.20.1. Hospitals & Clinics 15.20.2. ENTC Specialists 15.20.3. Research Institute 15.20.4. Others 15.21. South America Acute Sinusitis Market Attractiveness Analysis 15.21.1. By Type of Sinusitis 15.21.2. By Treatment of Sinusitis 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Bayer AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. AstraZeneca Plc 16.3.3. Eli Lilly And Company 16.3.4. Bristol-Myers Squibb 16.3.5. Sanofi 16.3.6. Abbott 16.3.7. Merck & Co, Inc. 16.3.8. Bristol-Myers Squibb 16.3.9. Reddy’s Laboratory 16.3.10. Novartis AG 17. Primary Key Insights

About This Report

Report ID34868
Category Electronics
Published Dateoct 2019
No of Pages186
Contact Us